TY - JOUR
T1 - Chlorella vulgaris extracts as modulators of the health status and the inflammatory response of gilthead seabream juveniles (Sparus aurata)
AU - Reis, Bruno
AU - Ramos-Pinto, Lourenço
AU - Cunha, Sara A.
AU - Pintado, Manuela
AU - Silva, Joana Laranjeira da
AU - Dias, Jorge
AU - Conceição, Luís
AU - Matos, Elisabete
AU - Costas, Benjamín
N1 - Funding Information:
This work was funded by Compete 2020, Lisboa 2020, Algarve 2020, Portugal 2020, and the European Union through FEDER in the framework of VALORMAR project (POCI-01-0247-FEDER-024517) and by national funds through the Foundation for Science and Technology (FCT) within the scope of UIDB/50016/2020, UIDB/04423/2020, and UIDP/04423/2020. The views expressed in this work are the sole responsibility of the authors. B. Reis was supported by FCT, Soja de Portu-gal, SA, and Sparos Lda., through the grant PD/BDE/129262/2017. S.A. Cunha and B. Costas were supported by FCT, through grants SFRH/BD/144155/2019 and 2020.00290.CEECIND, respectively.
Funding Information:
Funding: This work was funded by Compete 2020, Lisboa 2020, Algarve 2020, Portugal 2020, and the European Union through FEDER in the framework of VALORMAR project (POCI-01-0247-FEDER-024517) and by national funds through the Foundation for Science and Technology (FCT) within the scope of UIDB/50016/2020, UIDB/04423/2020, and UIDP/04423/2020. The views expressed in this work are the sole responsibility of the authors. B. Reis was supported by FCT, Soja de Portugal, SA, and Sparos Lda., through the grant PD/BDE/129262/2017. S.A. Cunha and B. Costas were supported by FCT, through grants SFRH/BD/144155/2019 and 2020.00290.CEECIND, respectively.
Publisher Copyright:
© 2022 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2022/7
Y1 - 2022/7
N2 - This study aimed to evaluate the effects of short-term supplementation, with 2% Chlorella vulgaris (C. vulgaris) biomass and two 0.1% C. vulgaris extracts, on the health status (experiment one) and on the inflammatory response (experiment two) of gilthead seabream (Sparus aurata). The trial comprised four isoproteic (50% crude protein) and isolipidic (17% crude fat) diets. A fishmeal-based (FM), practical diet was used as a control (CTR), whereas three experimental diets based on CTR were further supplemented with a 2% inclusion of C. vulgaris biomass (Diet D1); 0.1% inclusion of C. vulgaris peptide-enriched extract (Diet D2) and finally a 0.1% inclusion of C. vulgaris insoluble fraction (Diet D3). Diets were randomly assigned to quadruplicate groups of 97 fish/tank (IBW: 33.4 ± 4.1 g), fed to satiation three times a day in a recirculation seawater system. In experiment one, seabream juveniles were fed for 2 weeks and sampled for tissues at 1 week and at the end of the feeding period. Afterwards, randomly selected fish from each group were subjected to an inflammatory insult (experiment two) by intraperitoneal injection of inactivated gram-negative bacteria, following 24 and 48 h fish were sampled for tissues. Blood was withdrawn for haematological pro-cedures, whereas plasma and gut tissue were sampled for immune and oxidative stress parameters. The anterior gut was also collected for gene expression measurements. After 1 and 2 weeks of feed-ing, fish fed D2 showed higher circulating neutrophils than seabream fed CTR. In contrast, dietary treatments induced mild effects on the innate immune and antioxidant functions of gilthead sea-bream juveniles fed for 2 weeks. In the inflammatory response following the inflammatory insult, mild effects could be attributed to C. vulgaris supplementation either in biomass form or extract. However, the C. vulgaris soluble peptide-enriched extract seems to confer a protective, anti-stress effect in the gut at the molecular level, which should be further explored in future studies.
AB - This study aimed to evaluate the effects of short-term supplementation, with 2% Chlorella vulgaris (C. vulgaris) biomass and two 0.1% C. vulgaris extracts, on the health status (experiment one) and on the inflammatory response (experiment two) of gilthead seabream (Sparus aurata). The trial comprised four isoproteic (50% crude protein) and isolipidic (17% crude fat) diets. A fishmeal-based (FM), practical diet was used as a control (CTR), whereas three experimental diets based on CTR were further supplemented with a 2% inclusion of C. vulgaris biomass (Diet D1); 0.1% inclusion of C. vulgaris peptide-enriched extract (Diet D2) and finally a 0.1% inclusion of C. vulgaris insoluble fraction (Diet D3). Diets were randomly assigned to quadruplicate groups of 97 fish/tank (IBW: 33.4 ± 4.1 g), fed to satiation three times a day in a recirculation seawater system. In experiment one, seabream juveniles were fed for 2 weeks and sampled for tissues at 1 week and at the end of the feeding period. Afterwards, randomly selected fish from each group were subjected to an inflammatory insult (experiment two) by intraperitoneal injection of inactivated gram-negative bacteria, following 24 and 48 h fish were sampled for tissues. Blood was withdrawn for haematological pro-cedures, whereas plasma and gut tissue were sampled for immune and oxidative stress parameters. The anterior gut was also collected for gene expression measurements. After 1 and 2 weeks of feed-ing, fish fed D2 showed higher circulating neutrophils than seabream fed CTR. In contrast, dietary treatments induced mild effects on the innate immune and antioxidant functions of gilthead sea-bream juveniles fed for 2 weeks. In the inflammatory response following the inflammatory insult, mild effects could be attributed to C. vulgaris supplementation either in biomass form or extract. However, the C. vulgaris soluble peptide-enriched extract seems to confer a protective, anti-stress effect in the gut at the molecular level, which should be further explored in future studies.
KW - Fish robustness
KW - Functional feeds
KW - Innate immunity
KW - Protein hydrolysate
UR - http://www.scopus.com/inward/record.url?scp=85132982855&partnerID=8YFLogxK
U2 - 10.3390/md20070407
DO - 10.3390/md20070407
M3 - Article
C2 - 35877700
AN - SCOPUS:85132982855
SN - 1660-3397
VL - 20
JO - Marine Drugs
JF - Marine Drugs
IS - 7
M1 - 407
ER -